These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16299104)

  • 21. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
    Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
    Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs.
    Kiaris H; Schally AV; Busto R; Halmos G; Artavanis-Tsakonas S; Varga JL
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):196-200. PubMed ID: 11773624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor.
    Kiaris H; Chatzistamou I; Schally AV; Halmos G; Varga JL; Koutselini H; Kalofoutis A
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9512-7. PubMed ID: 12867592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity.
    Bédard K; Strecko J; Thériault K; Bédard J; Veyrat-Durebex C; Gaudreau P
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E740-51. PubMed ID: 18285528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
    Schally AV; Varga JL; Engel JB
    Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):33-43. PubMed ID: 18084344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Janus kinase/signal transducer and activator of transcription 3 pathway by growth hormone-releasing hormone.
    Siejka A; Schally AV; Barabutis N
    Cell Mol Life Sci; 2010 Mar; 67(6):959-64. PubMed ID: 20012909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
    Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas.
    Hashimoto K; Koga M; Motomura T; Kasayama S; Kouhara H; Ohnishi T; Arita N; Hayakawa T; Sato B; Kishimoto T
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2933-9. PubMed ID: 7559877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A correlation of endocrine and anticancer effects of some antagonists of GHRH.
    Kovács M; Schally AV; Hohla F; Rick FG; Pozsgai E; Szalontay L; Varga JL; Zarándi M
    Peptides; 2010 Oct; 31(10):1839-46. PubMed ID: 20633588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel.
    Hohla F; Schally AV; Szepeshazi K; Varga JL; Buchholz S; Köster F; Heinrich E; Halmos G; Rick FG; Kannadka C; Datz C; Kanashiro CA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14513-8. PubMed ID: 16983095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the chicken growth hormone-releasing hormone receptor (GHRH-R) mRNA and gene: regulation of anterior pituitary GHRH-R mRNA levels by homologous and heterologous hormones.
    Porter TE; Ellestad LE; Fay A; Stewart JL; Bossis I
    Endocrinology; 2006 May; 147(5):2535-43. PubMed ID: 16469800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.
    Barabutis N; Tsellou E; Schally AV; Kouloheri S; Kalofoutis A; Kiaris H
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5575-9. PubMed ID: 17372203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colon.
    Hohla F; Moder A; Mayrhauser U; Hauser-Kronberger C; Schally AV; Varga JL; Zarandi M; Buchholz S; Huber R; Aigner E; Ritter M; Datz C
    Int J Oncol; 2008 Jul; 33(1):137-43. PubMed ID: 18575759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular distribution of growth hormone-releasing hormone receptor in human reproductive system and breast and prostate cancers.
    Gallego R; Pintos E; García-Caballero T; Raghay K; Boulanger L; Beiras A; Gaudreau P; Morel G
    Histol Histopathol; 2005 Jul; 20(3):697-706. PubMed ID: 15944917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels.
    Aleppo G; Moskal SF; De Grandis PA; Kineman RD; Frohman LA
    Endocrinology; 1997 Mar; 138(3):1058-65. PubMed ID: 9048609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive.
    Kővári B; Rusz O; Schally AV; Kahán Z; Cserni G
    APMIS; 2014 Sep; 122(9):824-31. PubMed ID: 24479854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.
    Halmos G; Schally AV; Varga JL; Plonowski A; Rekasi Z; Czompoly T
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10555-60. PubMed ID: 10962030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target.
    Xiong X; Ke X; Wang L; Yao Z; Guo Y; Zhang X; Chen Y; Pang CP; Schally AV; Zhang H
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6726-6732. PubMed ID: 32156725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.